Stay updated on Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.

Latest updates to the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of evobrutinib compared to teriflunomide for treating Relapsing Multiple Sclerosis, while adding a new revision number and collaborators.SummaryDifference9%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding dates of January 14, 2025, and March 21, 2025.SummaryDifference0.2%
- Check38 days agoChange DetectedThe page has been updated to reflect a new version release and the most recent update date, indicating a shift in the timeline of information presented.SummaryDifference0.2%
- Check45 days agoChange DetectedThe webpage has updated its date references, adding new dates in March 2025 while removing older dates from December 2024 and January 2025.SummaryDifference0.3%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
Stay in the know with updates to Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.